MS&AD Ventures

Activity from announced rounds

Activity in this selectionSeed
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$18.5M
2 disclosed · full round size, not this investor’s share

By stage

Seed2

By primary sector

AI1
Healthtech1

By country

United Kingdom1
United States1

Rounds

2 in this selection
Axo Longevity

Axo Longevity is a preventive-health membership that combines recurring laboratory testing with personalised insights and an AI health coach.

$5MSeed
Participant
Unreasonable Labs

Builds an AI reasoning engine to generate scientific hypotheses across chemistry, materials science, and biology for industrial R&D

$13.5MSeed
Role not disclosed